Highline Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Highline Wealth Partners's ABBV Position: Q3 2026 in Review
Highline Wealth Partners increased its AbbVie (ABBV) stake by 37% in Q3 2026, buying an estimated $39.7K and bringing the position to 574 shares worth $150K. The position accounts for 0.03% of the portfolio, ranked #145.
Highline Wealth Partners first reported a position in ABBV in Q3 2022 and has held it in 17 quarters since. 2,171 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Highline Wealth Partners held 574 shares of AbbVie worth $150K as of Q3 2026.
- Highline Wealth Partners bought 155 AbbVie shares in Q3 2026, an estimated $39.7K.
- AbbVie made up 0.03% of Highline Wealth Partners's portfolio in Q3 2026, its #145 holding.
- Highline Wealth Partners first reported a position in AbbVie in Q3 2022 and has held it in 17 quarters since.
- 2,171 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.